Neurosearch
Ballerup · Founded 1989
About Neurosearch
NeuroSearch (NEUR) is a Scandinavian biopharmaceutical company listed on the Nasdaq OMX Copenhagen A/S. The core business of the company covers the development of novel pharmaceutical agents, based on a broad and well-established drug discovery platform focusing on ion channels and central nervous system (CNS) disorders. A substantial share of the activities is partner financed through strategic alliances with Eli Lilly and Company, Janssen Pharmaceutica and GlaxoSmithKline (GSK), and a license collaboration with Abbott. In addition, NeuroSearch has a broad portfolio of preclinical drug candidates and holds equity interests in several biotech companies. The company has approximately 220 employees with activities in Ballerup and Gothenburg.
Company Facts
- Founded: 1989
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $14.3M
- Funding stage: IPO
- Last round: Series Unknown (Aug 2009)
- Ticker: cph:NEUR
- Website: neurosearch.com
- Phone: +45 4460-8000
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/neurosearch-2916799 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.